Highlights of the Annual Dialysis Conference: Chronic Kidney Disease Related-Anemia

February 18-20, 2007; Denver, Colorado

Anne G. Le, PharmD, RPh


April 02, 2007

In This Article


Regarding the management of anemia and iron deficiency in patients with CKD, a wealth of provocative data has been emerging. Novel agents for the therapeutic stimulation of erythropoiesis may allow for extended dosing and more convenient administration, which may be of great benefit to clinicians and patients.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.